Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction notice to "Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice" [Life Sci. 340 (2024) 122449].
Wang H, Jayasankar N, Thamaraikani T, Viktor P, Mohany M, Al-Rejaie SS, Alammar HK, Anad E, Alhili F, Hussein SF, Amin AH, Lakshmaiya N, Ahsan M, Bahrami A, Akhavan-Sigari R. Wang H, et al. Among authors: thamaraikani t. Life Sci. 2024 Jun 15;347:122679. doi: 10.1016/j.lfs.2024.122679. Epub 2024 May 1. Life Sci. 2024. PMID: 38697877 No abstract available.
Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Izzati Mat Rani NN, Wu YS, Jeyabalan S. Velayutham NK, et al. Among authors: thamaraikani t. Front Pharmacol. 2024 Jan 17;15:1343756. doi: 10.3389/fphar.2024.1343756. eCollection 2024. Front Pharmacol. 2024. PMID: 38299157 Free PMC article.
Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice.
Wang H, Jayasankar N, Thamaraikani T, Viktor P, Mohany M, Al-Rejaie SS, Alammar HK, Anad E, Alhili F, Hussein SF, Amin AH, Lakshmaiya N, Ahsan M, Bahrami A, Akhavan-Sigari R. Wang H, et al. Among authors: thamaraikani t. Life Sci. 2024 Mar 1;340:122449. doi: 10.1016/j.lfs.2024.122449. Epub 2024 Jan 20. Life Sci. 2024. PMID: 38253310 Retracted.
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, Saadh MJ, Amajd A, Abo-Zaid MA, Castillo-Acobo RY, Ismail AH, Amin AH, Akhavan-Sigari R. Chehelgerdi M, et al. Among authors: thamaraikani t. Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0. Mol Cancer. 2023. PMID: 37814270 Free PMC article. Review.
Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Mat Rani NNI, Wu YS, Jeyabalan S. Velayutham NK, et al. Among authors: thamaraikani t. Front Pharmacol. 2023 Mar 28;14:1150270. doi: 10.3389/fphar.2023.1150270. eCollection 2023. Front Pharmacol. 2023. PMID: 37056983 Free PMC article.